8-KOther Events

CENTENE CORP 8-K Report, Corporate Update (Dec 13, 2019)

Filed December 13, 2019For Securities:CNC

Summary

Centene Corporation (CNC) announced on December 13, 2019, during its Investor Day, significant updates regarding the impending acquisition of WellCare. A key development for governance is the expected addition of two current WellCare board members, William Trubeck and James Dallas, to Centene's board upon the transaction's completion. Mr. Trubeck brings extensive financial and audit expertise from his executive roles at Waste Management and H&R Block, while Mr. Dallas offers over 30 years of experience in information technology, business strategy, and risk management from his tenure at Medtronic and Georgia-Pacific. This filing also reiterates important information regarding the WellCare acquisition, directing investors to previously filed documents like the Registration Statement and Joint Proxy Statement for comprehensive details. Investors are strongly encouraged to review these filings, which are available on the SEC's website and the respective companies' investor relations pages, to stay informed about the transaction's progress and its implications. The company emphasizes that this communication is informational and not an offer or solicitation related to securities.

Key Highlights

  • 1Centene's Board of Directors will expand with two WellCare board members upon acquisition completion.
  • 2William Trubeck, with strong financial and audit experience, is slated to join the board.
  • 3James Dallas, bringing IT and strategic risk management expertise, is also expected to join the board.
  • 4The announcement was made during Centene's Investor Day on December 13, 2019.
  • 5Filings related to the WellCare acquisition, including the Registration Statement and Joint Proxy Statement, are referenced for investors.
  • 6Investors are urged to read all SEC filings related to the WellCare transaction for important information.
  • 7The company reinforces that this communication does not constitute an offer to sell or solicit an offer to buy securities.

Frequently Asked Questions

Upon completion of the WellCare acquisition, Centene's board is expected to welcome William Trubeck and James Dallas, who are current members of WellCare's board.

William Trubeck has extensive financial, audit, and compliance expertise from executive roles at Waste Management and H&R Block. James Dallas brings over 30 years of experience in information technology, business strategy, and risk identification and mitigation, gained from his executive positions at Medtronic and Georgia-Pacific.

Investors can find comprehensive details about the WellCare transaction in the Registration Statement and Joint Proxy Statement previously filed with the SEC. These documents, along with any amendments or supplements, are available on the SEC's website (www.sec.gov) and on Centene's (www.centene.com) and WellCare's (www.ir.wellcare.com) investor relations pages.

No, this communication is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. Offers of securities can only be made through a prospectus that meets the requirements of Section 10 of the Securities Act of 1933.